시장보고서
상품코드
1152255

세계의 여행용 백신 시장-산업 규모, 점유율, 동향, 기회, 예측 : 조성별, 질환 증상별, 여행 유형별, 지역별(2017-2027년)

Travel Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Composition, By Disease Indication, By Travel Type and By Region

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 113 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 여행 백신 시장 규모는 예측 기간 동안 2023년에서 2027년까지 안정적인 속도로 성장할 것으로 예측됩니다.

시장 성장은 인플루엔자 발병률의 상승과 여행·관광 부문의 급성장 때문입니다. 게다가, 고유종이나 국경을 넘은 감염증 예방에 대한 의식 고양, 감염증의 증대를 막기 위한 보건 당국에 의한 엄격한 권고·규제가 여행용 백신의 채택을 뒷받침하는 요인이 되고 있습니다. 또한 COVID-19의 대유행으로 인해 감염 확대를 막기 위해 여행용 백신이 중시되고 있으며, 일반 시민의 감염증 확대에 대한 인식과 경계가 높아짐에 따라 여행용 백신의 수요는 앞으로 수년간 급증할 전망입니다.

세계의 여행용 백신(Travel Vaccine) 시장에 대해 조사 분석 했으며, 부문별·지역별 시장 규모/점유율 예측/시장 역학/기업 개요 등 체계적인 정보를 제공하고 있습니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 여행용 백신 시장에 대한 COVID-19의 영향

제5장 VOC(고객의 목소리)

  • 여행용 백신에 대한 관심
  • 여행용 백신 : 지역별
  • 여행용 백신 : 여행 유형별

제6장 세계의 여행용 백신 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 조성별(단제 백신, 혼합 백신)
    • 질환 증상별(A형 간염, DPT, 황열병, 장티푸스, B형 간염, 홍역·볼거리, 광견병, 수막염균, 수두, 일본 뇌염, 기타)
    • 여행 유형별(국내, 해외)
    • 지역별
  • 제품 시장 맵

제7장 북미 여행용 백신 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 조성별
    • 질환 증상별
    • 여행 유형별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제8장 유럽 여행용 백신 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 조성별
    • 질환 증상별
    • 여행 유형별
    • 국가별
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 아시아 태평양 여행용 백신 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 조성별
    • 질환 증상별
    • 여행 유형별
    • 국가별
  • 아시아 태평양 : 국가별 분석
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주
    • 싱가포르

제10장 남미 여행용 백신 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 조성별
    • 질환 증상별
    • 여행 유형별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동·아프리카 여행용 백신 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 조성별
    • 질환 증상별
    • 여행 유형별
    • 국가별
  • MEA : 국가별 분석
    • 남아프리카
    • 사우디 아라비아
    • UAE
    • 이스라엘
    • 터키

제12장 시장 역학

  • 촉진 요인
  • 과제

제13장 시장 동향과 개발

제14장 경쟁 상황

  • GlaxoSmithKline, plc.
  • Sanofi SA
  • Novartis International AG
  • Merck KGaA
  • Pfizer Inc.
  • AstraZeneca Plc.
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • CSL Limited
  • Johnson & Johnson

제15장 전략적 제안

LYJ 22.11.23

The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027. The market growth can be attributed to the rising incidences of flu and rapid growth in the travel and tourism sector. Travel vaccines, also known as travel immunizations, are vaccine shots that protect travelers from serious illnesses. Vaccines work by exposing the body to germs of the disease it will protect against by enabling the production of antibodies. Besides, increasing awareness regarding the prevention of endemics and transnational infections and stringent advisories and regulations by health authorities to prevent the rise of infectious diseases are some of the factors driving the adoption of travel vaccines. The travel and tourism industry has witnessed a robust growth in recent years with the rise in disposable income of middle-class population across the world. Moreover, increasing trend of exploring different cultures, traditions, spiritualism, rural and ethnic living is propelling the adoption of travel vaccines. The COVID-19 pandemic has led to an increased emphasis on travel vaccines to avoid the spread of infections. As the public is becoming more aware and alert around the spread of infectious diseases, the demand for travel vaccine is expected to proliferate in the coming years. Growth in tourism activities have also led to the booming travel vaccine business for market players.

Stringent Advisories and Regulations by Health Authorities to Aid the Market Growth

Vaccination for diseases mentioned in the United States Department of Health & Human Services such as chickenpox, cholera, COVID-19, diphtheria, influenza, Hepatitis A, Hepatitis B, pneumococcal, polio, rabies, rotavirus, rubella, shingles, tetanus, typhoid fever, whooping cough, and yellow fever is considered mandatory by some countries. These countries ask for mandatory vaccination proofs documented on an International Certification of Vaccination or Prophylaxis (ICVP) from travelers entering their country. Various countries' governments have implemented policies to prevent traveling citizens from travel-related infections. For instance, the National Health Services (NHS) organizes routine vaccination drives to prevent infectious diseases such as hepatitis A, typhoid, measles, mumps, yellow fever, among others. In addition, travelers coming for Hajj and Umrah in Saudi Arabia from various countries are required to show proof of vaccination for meningitis and seasonal influenza. Major countries such as the United States, Canada, Mexico, United Kingdom, Saudi Arabia, India, China, Japan, and Germany, among others, recommend travelers to be vaccinated for DPT. Increasing regulations for safe traveling are supporting the normalization of travel vaccines among travelers, which is expected to boost the market growth.

High Market Growth Potential in Emerging Nations

Rising personal disposable income of middle-class population in developing nations, owing to improving economic conditions, is increasing demand for travel and tourism. Travel and tourism is rapidly becoming a part of lifestyle for people in developing nations. Besides, growing awareness among population regarding various infections and disease that they could fall prey to while travelling to another country is boosting the travel vaccine market growth. Moreover, governments in developing regions are taking initiatives to create more awareness regarding infectious diseases, which is expected to fuel the growth of travel vaccines in the coming years.

Market Segmentation

The global travel vaccine market is segmented by composition, disease indication, travel type, and region. Based on composition, the market is divided into mono vaccines and combination vaccine. Based on disease indication, the market is divided into Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and others. Based on travel type, the market is bifurcated into domestic and international. The market analysis also studies the regional segmentation, divided among North America, Europe, Asia Pacific, Middle east and Africa, South America. The United States is expected to hold a significant share in the global travel vaccine market, owing to rising incidences of infectious diseases and increased spending by population on travelling in the region.

Market Players

Key players operating in the global travel vaccine market are: GlaxoSmithKline, plc., Sanofi S.A., Novartis International AG, Merck KGaA, Pfizer Inc., AstraZeneca Plc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, CSL Limited, Johnson & Johnson, among others.

Report Scope:

In this report, the global travel vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Travel Vaccine Market, By Composition:

  • Mono Vaccines
  • Combination Vaccines

Travel Vaccine Market, By Disease Indication:

  • Hepatitis A
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others

Travel Vaccine Market, By Type:

  • Domestic
  • International

Travel Vaccine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Singapore
    • South Korea
  • Europe & CIS
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • Saudi Arabia
    • Israel
    • UAE
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global travel vaccine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Travel Vaccine Market

5. Voice of Customer

  • 5.1. Travel Vaccination Awareness
  • 5.2. Travel Vaccination, By Region
  • 5.3. Travel Vaccination, By Travel Type

6. Global Travel Vaccine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Composition (Mono Vaccines v/s Combination Vaccines)
    • 6.2.2. By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others)
    • 6.2.3. By Travel Type (Domestic v/s International)
    • 6.2.4. By Region
  • 6.3. Product Market Map

7. North America Travel Vaccine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Composition
    • 7.2.2. By Disease Indication
    • 7.2.3. By Travel Type
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Travel Vaccine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Composition
        • 7.3.1.2.2. By Disease Indication
        • 7.3.1.2.3. By Travel Type
    • 7.3.2. Mexico Travel Vaccine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Composition
        • 7.3.2.2.2. By Disease Indication
        • 7.3.2.2.3. By Travel Type
    • 7.3.3. Canada Travel Vaccine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Composition
        • 7.3.3.2.2. By Disease Indication
        • 7.3.3.2.3. By Travel Type

8. Europe Travel Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Composition
    • 8.2.2. By Disease Indication
    • 8.2.3. By Travel Type
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Travel Vaccine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Composition
        • 8.3.1.2.2. By Disease Indication
        • 8.3.1.2.3. By Travel Type
    • 8.3.2. Germany Travel Vaccine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Composition
        • 8.3.2.2.2. By Disease Indication
        • 8.3.2.2.3. By Travel Type
    • 8.3.3. United Kingdom Travel Vaccine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Composition
        • 8.3.3.2.2. By Disease Indication
        • 8.3.3.2.3. By Travel Type
    • 8.3.4. Italy Travel Vaccine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Composition
        • 8.3.4.2.2. By Disease Indication
        • 8.3.4.2.3. By Travel Type
    • 8.3.5. Spain Travel Vaccine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Composition
        • 8.3.5.2.2. By Disease Indication
        • 8.3.5.2.3. By Travel Type

9. Asia-Pacific Travel Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Composition
    • 9.2.2. By Disease Indication
    • 9.2.3. By Travel Type
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Travel Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Composition
        • 9.3.1.2.2. By Disease Indication
        • 9.3.1.2.3. By Travel Type
    • 9.3.2. India Travel Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Composition
        • 9.3.2.2.2. By Disease Indication
        • 9.3.2.2.3. By Travel Type
    • 9.3.3. South Korea Travel Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Composition
        • 9.3.3.2.2. By Disease Indication
        • 9.3.3.2.3. By Travel Type
    • 9.3.4. Japan Travel Vaccine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Composition
        • 9.3.4.2.2. By Disease Indication
        • 9.3.4.2.3. By Travel Type
    • 9.3.5. Australia Travel Vaccine Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Composition
        • 9.3.5.2.2. By Disease Indication
        • 9.3.5.2.3. By Travel Type
    • 9.3.6. Singapore Travel Vaccine Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Composition
        • 9.3.6.2.2. By Disease Indication
        • 9.3.6.2.3. By Travel Type

10. South America Travel Vaccine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Composition
    • 10.2.2. By Disease Indication
    • 10.2.3. By Travel Type
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Travel Vaccine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Composition
        • 10.3.1.2.2. By Disease Indication
        • 10.3.1.2.3. By Travel Type
    • 10.3.2. Argentina Travel Vaccine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Composition
        • 10.3.2.2.2. By Disease Indication
        • 10.3.2.2.3. By Travel Type
    • 10.3.3. Colombia Travel Vaccine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Composition
        • 10.3.3.2.2. By Disease Indication
        • 10.3.3.2.3. By Travel Type

11. Middle East and Africa Travel Vaccine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Composition
    • 11.2.2. By Disease Indication
    • 11.2.3. By Travel Type
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Travel Vaccine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Composition
        • 11.3.1.2.2. By Disease Indication
        • 11.3.1.2.3. By Travel Type
    • 11.3.2. Saudi Arabia Travel Vaccine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Composition
        • 11.3.2.2.2. By Disease Indication
        • 11.3.2.2.3. By Travel Type
    • 11.3.3. UAE Travel Vaccine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Composition
        • 11.3.3.2.2. By Disease Indication
        • 11.3.3.2.3. By Travel Type
    • 11.3.4. Israel Travel Vaccine Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Composition
        • 11.3.4.2.2. By Disease Indication
        • 11.3.4.2.3. By Travel Type
    • 11.3.5. Turkey Travel Vaccine Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Composition
        • 11.3.5.2.2. By Disease Indication
        • 11.3.5.2.3. By Travel Type

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)

  • 14.1. GlaxoSmithKline, plc.
  • 14.2. Sanofi S.A.
  • 14.3. Novartis International AG
  • 14.4. Merck KGaA
  • 14.5. Pfizer Inc.
  • 14.6. AstraZeneca Plc.
  • 14.7. Abbott Laboratories, Inc.
  • 14.8. F. Hoffmann-La Roche AG
  • 14.9. CSL Limited
  • 14.10. Johnson & Johnson

15. Strategic Recommendations

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제